Polymorphisms in the ABC drug transporter gene MDR1

Area of Science:

• Pharmacology
• Genetics
• Biochemistry

Background:

• Drug levels are influenced by both metabolic enzymes (e.g., Cyp p450) and active transport processes.
• ATP-dependent efflux pumps, including P-glycoprotein (P-gp) and multidrug resistance proteins (MRPs), are key regulators of drug disposition.
• P-glycoprotein, encoded by the MDR1 gene, plays a critical role in drug bioavailability and central nervous system (CNS) concentrations.

Purpose of the Study:

• To investigate the influence of P-glycoprotein and related efflux pumps on drug pharmacokinetics.
• To explore the impact of genetic variations in the MDR1 gene on drug distribution and bioavailability.
• To understand the role of P-glycoprotein in drug resistance and overall drug pharmacology.

Main Methods:

• Analysis of knockout mouse models to study P-glycoprotein function.
• Conducting clinical studies to assess P-glycoprotein's role in human drug disposition.
• Identifying and analyzing functional genetic polymorphisms within the MDR1 gene.

Main Results:

• Experimental evidence confirms P-glycoprotein's significant influence on the pharmacology of various drugs.
• Studies using knockout mice and clinical data highlight P-gp's role in drug bioavailability and CNS penetration.
• Functional genetic polymorphisms in the MDR1 gene have been identified as key factors affecting P-gp substrate distribution and bioavailability.

Conclusions:

• P-glycoprotein is a major determinant of drug transport and significantly impacts drug bioavailability and tissue distribution.
• Genetic variations in the MDR1 gene can lead to altered drug responses due to changes in P-glycoprotein activity.
• Understanding P-glycoprotein's role and its genetic polymorphisms is crucial for optimizing drug therapy and overcoming drug resistance.